Costa Rica is set to begin clinical trials on antibody-rich plasma that has been extracted from horses with the purpose of treating COVID-19 patients.
Two versions of the plasma were shown to inhibit the infectivity of SARS-CoV-2, the virus that causes COVID-19, in tests performed at the National Center for Biodefense and Infectious Diseases in the United States.
Problem, Solution, SitRep, or ?:
Recent Comments